Friday, 14 July 2017

Detailed Report on US Cartilage Repair 2017

US Market Report for Cartilage Repair 2017 - MedCore is a new market research publication announced by Reportstack. 
General Report Contents• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
By far, the fastest growing segment over the forecast period is represented by microfracture adjunct market. The procedure is complementary to microfracture which provides a very large market for implant sales to penetrate. No other segment is expected to grow as strongly. 
Microfracture procedures are the standard by which new products and procedures are compared. Their positive results and low cost creates barriers for new product entry, as new products and procedures on the market must surpass microfracture procedures in terms of cost or efficacy.
Surgeons repairing cartilage damage are no doubt awaiting new technological developments which may likely involve stem cell products offered at more competitive prices. However, an implant that will truly impact the market by providing clinically backed, long-term cartilage repair at low cost remains years away.
Companies Mentioned
Arthrex Smith & Nephew DePuy Mitek Zimmer Biomet Conmed Linvatec MTF RTI Biologics Stryker LifeNet Health JRF Verocel Wright Medical Parcus Medical Medtronic Allosource Tissue Regenix Synthasome Artelon Integra LifeSciences Others include: Tissue banks, Ceterix, LifeLink, MedShape, Osiris Therapeutics, Rotation Medical, Vivex, etc.
Debora White
Manager - Marketing
Ph: +1-888-789-6604
ReportstackMarket Research

No comments:

Post a Comment